tradingkey.logo

Artivion Inc

AORT

31.630USD

+0.710+2.30%
Market hours ETQuotes delayed by 15 min
1.35BMarket Cap
LossP/E TTM

Artivion Inc

31.630

+0.710+2.30%
More Details of Artivion Inc Company
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Company Info
Ticker SymbolAORT
Company nameArtivion Inc
IPO dateFeb 12, 1993
CEOMr. James Patrick (Pat) Mackin
Number of employees1600
Security typeOrdinary Share
Fiscal year-endFeb 12
Address1655 Roberts Boulevard N W
CityKENNESAW
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code30144
Phone17704193355
Websitehttps://artivion.com/
Ticker SymbolAORT
IPO dateFeb 12, 1993
CEOMr. James Patrick (Pat) Mackin
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
+7.55%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
+6.92%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
121.36K
+10.09%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+10.15%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+13.32%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
48.71K
-45.78%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-21.64%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
188.49K
+7.55%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+4.40%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+4.41%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
142.38K
+6.92%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+5.12%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
121.36K
+10.09%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Aortic stent grafts
36.60M
36.98%
On X
21.57M
21.80%
Surgical sealants
18.11M
18.29%
Other
2.52M
2.54%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.46%
Macquarie Investment Management
6.80%
Perceptive Advisors LLC
6.54%
Fidelity Management & Research Company LLC
6.51%
The Vanguard Group, Inc.
6.49%
Other
60.19%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.46%
Macquarie Investment Management
6.80%
Perceptive Advisors LLC
6.54%
Fidelity Management & Research Company LLC
6.51%
The Vanguard Group, Inc.
6.49%
Other
60.19%
Shareholder Types
Shareholders
Proportion
Investment Advisor
57.95%
Investment Advisor/Hedge Fund
28.93%
Private Equity
6.54%
Individual Investor
5.25%
Hedge Fund
1.99%
Research Firm
1.20%
Pension Fund
1.06%
Bank and Trust
0.43%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
390
44.18M
103.45%
+2.14M
2025Q1
402
44.36M
103.89%
+1.66M
2024Q4
380
41.09M
97.75%
+880.04K
2024Q3
367
38.98M
93.02%
-790.24K
2024Q2
349
38.52M
92.17%
-784.32K
2024Q1
347
38.26M
91.68%
-2.02M
2023Q4
342
37.08M
90.20%
-1.57M
2023Q3
339
37.01M
90.02%
-1.95M
2023Q2
331
37.22M
87.77%
-1.77M
2023Q1
335
37.61M
88.87%
-1.51M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.75M
13.46%
-106.89K
-1.83%
Mar 31, 2025
Macquarie Investment Management
2.90M
6.8%
+166.78K
+6.09%
Mar 31, 2025
Perceptive Advisors LLC
2.79M
6.54%
--
--
Mar 31, 2025
Fidelity Management & Research Company LLC
2.78M
6.51%
+1.72M
+161.42%
Mar 31, 2025
The Vanguard Group, Inc.
2.77M
6.49%
-22.88K
-0.82%
Mar 31, 2025
Juniper Investment Company, LLC
2.10M
4.91%
--
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.94M
4.54%
-50.93K
-2.56%
Mar 31, 2025
Wellington Management Company, LLP
1.73M
4.05%
+67.33K
+4.06%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.59%
-13.74K
-0.89%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.31M
3.07%
-160.12K
-10.87%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
AAM Sawgrass US Small Cap Quality Growth ETF
2.93%
Unusual Whales Subversive Democratic Trading ETF
2.48%
ROBO Global Healthcare Technology & Innovation ETF
1.7%
SPDR S&P Health Care Equipment ETF
1.64%
Invesco Dorsey Wright Healthcare Momentum ETF
1.53%
Invesco S&P SmallCap Health Care ETF
0.85%
Invesco S&P SmallCap 600 Pure Growth ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.41%
Invesco S&P SmallCap Momentum ETF
0.39%
Invesco Dorsey Wright SmallCap Momentum ETF
0.37%
View more
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion2.93%
Unusual Whales Subversive Democratic Trading ETF
Proportion2.48%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.7%
SPDR S&P Health Care Equipment ETF
Proportion1.64%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion1.53%
Invesco S&P SmallCap Health Care ETF
Proportion0.85%
Invesco S&P SmallCap 600 Pure Growth ETF
Proportion0.5%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.41%
Invesco S&P SmallCap Momentum ETF
Proportion0.39%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion0.37%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI